Raptim Research Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 03-07-2024
- Paid Up Capital ₹ 7.50 M
as on 03-07-2024
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.46 Cr
as on 03-07-2024
- Satisfied Charges ₹ 12.51 Cr
as on 03-07-2024
- Revenue 4.37%
(FY 2023)
- Profit -22.00%
(FY 2023)
- Ebitda -15.88%
(FY 2023)
- Net Worth 26.99%
(FY 2023)
- Total Assets 24.89%
(FY 2023)
About Raptim Research
The Corporate was formerly known as Raptim Research Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹18.46 Cr. The company has closed loans amounting to ₹12.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajen Shah, Viraj Shah, Yellavajjhula Rao, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100MH2002PTC136230
- Company No.
136230
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Raptim Research?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viraj Shah  | Director | 10-Apr-2009 | Current |
| Rajen Shah | Whole-Time Director | 29-Jun-2004 | Current |
| Yellavajjhula Rao | Director | 01-Mar-2018 | Current |
| Meghana Shah | Additional Director | 04-Mar-2024 | Current |
Financial Performance of Raptim Research.
Raptim Research Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.37% increase. The company also saw a substantial fall in profitability, with a 22% decrease in profit. The company's net worth Soared by an impressive increase of 26.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raptim Research?
In 2023, Raptim Research had a promoter holding of 81.27% and a public holding of 18.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nova Chemdrugs Private LimitedActive 23 years 29 daysRajen Shah, Viraj Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Jan 2023 | ₹3.00 Cr | Open |
Others Creation Date: 24 May 2021 | ₹1.71 Cr | Open |
Tata Capital Financial Services Limited Creation Date: 27 Feb 2021 | ₹5.65 Cr | Open |
How Many Employees Work at Raptim Research?
Unlock and access historical data on people associated with Raptim Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raptim Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raptim Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
